- Home
- MNPR vs FRPH Comparison
MNPR vs FRPH Comparison
Compare MNPR & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNPR | FRPH |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 435.3M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNPR | FRPH |
|---|---|---|
| Price | $76.19 | $23.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $97.83 | N/A |
| AVG Volume (30 Days) | ★ 163.8K | 81.7K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $33,049,999.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $95.78 |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $21.00 | $21.68 |
| 52 Week High | $105.00 | $32.27 |
Technical Indicators
Market Signals| Indicator | MNPR | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 50.18 |
| Support Level | $74.51 | $23.30 |
| Resistance Level | $79.31 | $23.75 |
| Average True Range (ATR) | 6.38 | 0.58 |
| MACD | -0.93 | 0.08 |
| Stochastic Oscillator | 6.10 | 37.71 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).